Innovations in fetal monitoring during the pandemic
The COVID-19 pandemic changed how maternity services delivered almost every aspect of care. Fetal surveillance was especially affected because pregnancy monitoring often depends on scheduled hospital visits, specialist equipment, and close contact between patients and clinical teams. When clinics reduced non-urgent appointments and travel became difficult, providers had to preserve safety while limiting unnecessary exposure.
Fetal monitoring includes a broad range of practices, from intermittent auscultation and cardiotocography to ultrasound, Doppler assessment, fetal movement tracking, and biophysical profiling. During the pandemic, innovation was less about replacing every established method and more about combining digital tools, remote support, and carefully targeted in-person examinations.
The subject also reflects the wider scientific priorities associated with perinatal and neonatal medicine. The FAOPS 2020 archive preserves the setting of a planned Tokyo congress held with PREBIC AA 2020, where international specialists were expected to discuss research, clinical practice, and emerging approaches before the meeting was canceled in April 2020.
Why fetal surveillance needed to change
Routine antenatal care became harder to coordinate when hospitals introduced visitor restrictions, screening procedures, and new infection-control pathways. Pregnant patients with suspected exposure to the virus could require separate scheduling, while those living far from specialist centers faced additional travel barriers. Clinicians therefore had to distinguish monitoring that was essential from appointments that could be safely combined, delayed, or supported remotely.
The pandemic also exposed the vulnerability of highly centralized care. A conventional model may require a patient to travel to a hospital for blood pressure measurement, fetal heart-rate recording, ultrasound, and consultation. If any part of that pathway became unavailable, the entire appointment could be disrupted. Flexible fetal assessment sought to divide care into components that could happen at home, in a local clinic, or at a tertiary center.
Safety remained the primary standard. Remote monitoring was useful only when the data could be interpreted correctly, the device was reliable, and a clear escalation pathway existed. A lower-contact model could reduce infection risk, but it could not compromise timely intervention for growth restriction, reduced fetal movement, pre-eclampsia, diabetes, or other complications.
Remote cardiotocography and connected devices
Remote cardiotocography became one of the most visible areas of development. Portable systems can record fetal heart rate and uterine activity outside a traditional labor ward, then transmit the tracing to a midwife, obstetrician, or maternal-fetal medicine specialist. Depending on the system, the patient may attend a community site or perform supervised monitoring at home.
These devices vary in their level of automation. Some use wireless transducers that still require careful positioning, while others use wearable sensors designed to support greater mobility. Cloud-based platforms can allow authorized clinicians to review recordings, document interpretations, and contact patients without requiring every person to remain in a hospital waiting area.
However, a digital tracing is not automatically a dependable tracing. Signal loss, maternal heart-rate confusion, poor sensor placement, and gaps in connectivity can create false reassurance or unnecessary referrals. Remote CTG therefore works best when users receive practical instruction and when staff can verify questionable recordings promptly.
Patient-facing tools also expanded. Mobile applications allowed users to report fetal movement, symptoms, contractions, and home blood pressure readings. These tools supported communication, but they did not replace clinical judgment. A movement-counting application, for example, can help identify a change in an individual pattern, yet any concern still requires direct assessment according to local guidance.
Ultrasound, artificial intelligence, and decision support
Ultrasound services had to balance diagnostic value with reduced appointment density. Some clinics grouped scans and consultations into a single visit, while others created dedicated pathways for patients requiring serial growth assessment or Doppler studies. Portable ultrasound systems offered additional flexibility in selected settings, particularly where a trained operator could work outside a large hospital.
Artificial intelligence and machine learning attracted growing interest during this period. Algorithms can assist with fetal heart-rate interpretation, identify patterns associated with hypoxia, or support image analysis. Their potential value lies in helping clinicians manage large volumes of information and draw attention to recordings that may need urgent review.
The technology still requires careful validation. Fetal heart-rate patterns are influenced by gestational age, medications, labor status, maternal conditions, and technical quality. An algorithm trained on one population or device may perform differently in another. Transparent evaluation, human oversight, and continuous monitoring for bias are necessary before automated decision support becomes part of routine care.
Digital systems also create governance responsibilities. Patient data must be encrypted during transmission and storage, access should be limited by role, and records must remain integrated with the clinical chart. Clear consent procedures are important when data are used for research or algorithm development. Innovation is credible only when privacy and accountability develop alongside technical capability.
Comparing approaches to pandemic-era monitoring
Different monitoring methods offered different combinations of clinical detail, accessibility, and infection-control value. No single option suited every pregnancy. The appropriate choice depended on gestational age, risk status, local resources, the patient’s ability to use equipment, and the availability of rapid in-person assessment.
| Approach | Main benefit | Key limitation | Best use during a pandemic |
|---|---|---|---|
| Remote cardiotocography | Provides a fetal heart-rate tracing away from hospital settings | Signal quality and device placement can be inconsistent | Selected high-risk follow-up with clinical oversight |
| Home blood pressure and symptom reporting | Supports screening for hypertensive disease and clinical deterioration | Relies on accurate equipment and patient instruction | Frequent review between scheduled visits |
| Telehealth consultation | Reduces travel and face-to-face contact | Cannot replace physical examination or imaging | Results review, education, triage, and care planning |
| Portable ultrasound | Brings imaging closer to local or community services | Requires trained operators and reliable equipment | Targeted assessment where referral travel is difficult |
| Fetal movement applications | Encourages awareness of changes in perceived movement | Does not diagnose the cause of reduced movement | Patient education and early prompts to seek care |
| AI-assisted interpretation | May help prioritize concerning recordings | Requires validation and expert confirmation | Decision support within established clinical pathways |
The comparison shows why hybrid care became important. A patient might complete a telehealth consultation, record blood pressure at home, attend a local CTG appointment, and travel to a specialist unit only when ultrasound or further assessment was necessary. This arrangement reduced avoidable contact while preserving access to high-acuity services.
Equity had to remain central. Remote monitoring assumes access to a smartphone, stable internet, electricity, transportation for equipment collection, and enough privacy to communicate with clinicians. Language barriers, disability, low digital literacy, and financial constraints could all limit participation. Services that relied on technology needed telephone alternatives, community support, and interpreter access rather than treating digital engagement as universal.
Human factors and clinical workflow
Successful implementation depended as much on workflow design as on hardware. Teams needed protocols defining who could prescribe home monitoring, how devices would be issued and cleaned, when readings would be reviewed, and what would happen if a patient could not transmit data. Without these details, a new system could add administrative work without improving safety.
Remote care also changed professional roles. Midwives often became central coordinators of digital monitoring, patient education, and early triage. Obstetricians and fetal medicine specialists needed access to standardized recordings and concise summaries. Technical support became part of clinical reliability because a failed connection could delay evaluation of a potentially serious symptom.
Patients needed clear instructions that were easy to follow under stress. Written guidance could explain how to apply sensors, measure blood pressure, report reduced fetal movement, and contact the maternity unit. Demonstration and teach-back methods were valuable because they revealed misunderstandings before the patient relied on the device independently.
Communication should also acknowledge uncertainty. A normal home reading cannot guarantee that a pregnancy is uncomplicated, and a poor-quality recording should not be interpreted as a reassuring result. Clinicians had to explain the limits of each tool while ensuring patients knew which warning signs required immediate contact.
Research priorities after the emergency phase
The rapid adoption of remote fetal monitoring created opportunities for research, but emergency use should not be confused with proof of long-term effectiveness. Studies need to examine perinatal outcomes, false-positive referrals, missed complications, patient experience, staff workload, and cost. Comparisons should include rural and urban populations, different levels of digital access, and a range of maternal and fetal risk profiles.
Standardization is another priority. Researchers and clinical organizations can improve interoperability by defining common data formats, reporting requirements, and quality measures for remote CTG, ultrasound images, and home observations. Shared standards make it easier to compare services and reduce the risk of isolated systems that cannot communicate with hospital records.
Training deserves equal attention. A clinician interpreting a remotely acquired tracing needs confidence in both fetal physiology and the technical limitations of the device. Patients need practical education that reflects their language, culture, and circumstances. Simulation-based training can help teams rehearse poor signal quality, sudden symptom escalation, and equipment failure.
Future programs should also measure whether innovation improves experience without shifting responsibility unfairly onto pregnant patients. Convenience is valuable, but patients should not be expected to monitor complex conditions alone. The strongest models preserve a reliable clinical relationship and use technology to make that relationship more responsive.
Practical recommendations for resilient services
A balanced program can combine established fetal assessment with carefully selected digital tools. The following actions help protect quality while reducing unnecessary exposure:
- Create risk-based pathways that specify which patients are suitable for remote monitoring and which require direct assessment.
- Pair every home device with training, technical support, documented review times, and an escalation protocol.
- Combine telehealth with local examination, ultrasound, and laboratory services rather than treating virtual care as a complete substitute.
- Provide non-digital alternatives, interpreters, accessible equipment, and community-based support for patients who cannot use connected technologies.
- Audit clinical outcomes, data security, patient experience, and unequal access before expanding a remote monitoring program.
These measures are useful beyond a pandemic. Seasonal outbreaks, severe weather, transport disruption, and shortages of specialist staff can all interrupt conventional antenatal services. A flexible pathway gives clinicians more ways to maintain contact while preserving a clear route to urgent care.
The most valuable innovation is therefore organizational as well as technological. Reliable referral networks, shared records, trained staff, and informed patients can turn individual devices into a coherent system. Without that structure, even advanced sensors and predictive software remain disconnected tools.
Perinatal teams can use the lessons of pandemic-era care to design monitoring services that are safer, more adaptable, and more inclusive. Review current pathways, identify appointments that can be supported remotely, strengthen escalation arrangements, and evaluate each change against maternal and neonatal outcomes. Building that evidence-based framework now will help ensure that fetal surveillance remains dependable when the next disruption arrives.
